HELICOBACTER PYLORI INFECTIONS

This study tests whether adding bismuth to a 14-day course of vonoprazan and amoxicillin works better at clearing H. pylori infection than the two-drug regimen alone. About 990 adults who have not been treated before will take part. The main goal is to see which approach eradicat…

This study looks at whether treating Helicobacter pylori (a stomach infection) can also improve metabolic syndrome—a group of conditions like high blood sugar, cholesterol, and belly fat. About 120 adults with both H. pylori and metabolic syndrome will receive standard antibiotic…

This study tests a newer acid-blocking drug (vonoprazan) against a standard one, each combined with vitamin D or probiotics, to treat H. pylori infection. About 66 adults with confirmed H. pylori will receive one of three treatments for two weeks. The goal is to see which combina…

This study tests whether a 14-day treatment using just two medications (vonoprazan and an antibiotic) works as well as the standard four-drug regimen for clearing H. pylori, a bacteria that can cause stomach ulcers and cancer. About 372 adults who have never been treated for H. p…

This study is testing a new, non-invasive way to diagnose H. pylori infection in children using a stool sample instead of an endoscopy (a tube down the throat). The goal is to see if the stool test is as accurate as the standard biopsy method. About 188 children aged 16 and under…

This study is a large registry that will follow 10,000 people in Shandong Province who are being treated for H. pylori infection, a common stomach bug that can lead to ulcers and cancer. Researchers will track which treatments work best, how safe they are, and how costs compare i…

This study looks at how common Helicobacter pylori (a stomach germ linked to cancer) is in adults without stomach symptoms who are already getting a screening colonoscopy. About 1,000 participants will also have a stomach exam (gastroscopy) during the same visit, with small tissu…